CUSIP 816212302COM NEWRNACQ4 2025
14 filings · latest Mar 13, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 1.37M | $9.86M |
| 2 | Blackrock, Inc. | 609.7K | $4.40M |
| 3 | Vanguard Group Inc | 541.2K | $3.90M |
| 4 | 683 Capital Management, LLC | 280.0K | $2.02M |
| 5 | Erste Asset Management Gmbh | 271.7K | $1.96M |
| 6 | Geode Capital Management, LLC | 255.5K | $1.84M |
| 7 | State Street Corp | 199.0K | $1.43M |
| 8 | Marshall Wace, LLP | 178.1K | $1.28M |
| 9 | Privium Fund Management B.V. |
| 4 | Apr 25, 2025 | Jpmorgan Chase &Amp; Co. | 13G | 6.1% | 1.68M | SEC |
| 5 | Feb 12, 2025 | Fmr LLC | 13G/A | 9.4% | 2.42M | SEC |
| 6 | Jan 15, 2025 | Timothy A. Springer | 13D/A | 36.9% | — | SEC |
| 7 | Dec 23, 2024 | Timothy A. Springer | 13D/A | 36.8% | — | SEC |
| 8 | Nov 18, 2024 | Springer Timothy A | 13D/A | 37.1% | 9.48M | SEC |
| 9 | Oct 15, 2024 | Kalayoglu Murat | 13D/A | 19.9% | 5.06M | SEC |
| 10 | Oct 4, 2024 | Springer Timothy A | 13D/A | 37.6% | 9.05M | SEC |
See the full Schedule 13D/13G history for Cartesian Therapeutics Inc.
Unlock full history| 172.5K |
| $1.24M |
| 10 | Millennium Management LLC | 164.4K | $1.19M |